Project Grant HT94252310103

Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $712K
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Park, MD 20742, USA
Similar Awards
The University of Maryland, College Park was awarded a $349,778 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund an evaluation of mechanical loads on an osseointegrated implant during locomotor activities of daily living from May 2021 through May 2024. Through this funding, University of Maryland researchers will investigate how mechanical forces impact bone-implanted prosthetics during...
The University of Maryland, Baltimore was awarded a two-year, $154,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research into regulating the activity of poly (ADP-ribose) polymerase or PARP enzyme through ubiquitin E3 ligase RNF6 in prostate cancer. As part of the Military Medical Research and Development program's goal of transforming military and public health through innovative medical research, this...
The University of Maryland, Baltimore received a $308,821 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of a novel medical device called the TRANSESOPHAGEAL AORTIC BLOOD FLOW OCCLUDER to control non-compressible torso hemorrhage from January 15, 2022 to January 14, 2024. The device aims to transform trauma care for service members and the public through innovative...
The University of Maryland, Baltimore (UMB) was awarded a $587,271 Project Grant from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), to conduct research on "DUAL INHIBITION OF PARP AND IL-6 AS A NOVEL THERAPEUTIC APPROACH FOR BRCA-MUTATED TRIPLE-NEGATIVE BREAST CANCER." This research project will occur from July 1, 2024 to June 30, 2027. The Military Medical Research and Development program supports a...
The University of Illinois was awarded a $1,499,728 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2023, will fund research to investigate a novel approach to reverse volumetric muscle loss following transfemoral amputations, with the goal of improving mobility and function. The research aims to transform health care for service members and the American public through innovative biomedical...
The University of Texas Health Science Center at Houston was awarded a $1,498,514 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program. The grant will fund research from September 2022 through September 2026 to improve functional performance in transfemoral amputees through somatosensory augmentation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The University of Maryland, College Park received a $772,251 federal Project Grant award from the Department of Defense's Basic, Applied, and Advanced Research in Science and Engineering program (CFDA 12.630) to support research and development work with potential national defense and civilian applications. The award, effective December 1, 2024 through February 28, 2025, will fund advanced research on topics such as quantum computing, space exploration technologies, and the development of...
The University of Maryland, College Park was awarded a $256,065 Project Grant from the Department of the Army Materiel Command Research Development and Engineering Command to support research enabling human-centric autonomous systems. The grant period runs from February 1, 2023 through January 31, 2024. The funding supports basic scientific research conducted by the University of Maryland under the Basic Scientific Research program (CFDA 12.431). This program aims to improve Army capabilities by...
The University of Maryland, Baltimore was awarded a $1.15 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on BPTF-Mediated Gene Regulation in Prostate Cancer from August 1, 2022 to July 31, 2025. As part of the Military Medical Research and Development program's goal of transforming health care for service members and the public through innovative biomedical research, this project aims...
This Project Grant from the Defense Health Agency provides $349,939 to the University of Colorado Denver under the Military Medical Research and Development federal grant program (CFDA 12.420) from February 1, 2023 to January 31, 2026. The grant funds research on transfemoral osseointegrated prosthesis limb-load symmetry training. As the program description notes, the Military Medical Research and Development program supports basic, applied, and advanced biomedical research to improve military...

The University of Maryland, College Park will receive $712,011 through a three-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420).

The grant will support modeling and cross-sectional analysis of movement quality for service members using osseointegrated prostheses. Through June 2026, the University will conduct research to transform health care and investigate medical solutions for the battlefield. Findings will advance the Agency's goals of innovating impactful research solutions under its Military Medical Research and Development program.

The University, as prime awardee, will leverage its expertise in orthopedic research to deliver valuable insight for service members. Results have the potential to improve quality of life and care for those with limb amputations.

Generated 1/6/24, 10:55 PM